Skip to main content
NCBI home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1959 Dec;14(4):536–548. doi: 10.1111/j.1476-5381.1959.tb00961.x

The actions of bretylium: adrenergic neurone blocking and other effects

A L A Boura, A F Green
PMCID: PMC1481902  PMID: 13803290

Abstract

Bretylium caused a specific and lasting depression of many excitatory and inhibitory responses evoked by electrical stimulation of the peripheral sympathetic nervous system, probably by impairing conduction of impulses in adrenergic neurones with consequent failure of noradrenaline and adrenaline release. This effect, which will be referred to as the adrenergic neurone blocking action, was preceded by weak sympathomimetic effects. In the presence of bretylium the effects of adrenaline and noradrenaline were increased, as after sympathectomy. Concentrations producing blocking of adrenergic neurones did not prevent the release of adrenaline and noradrenaline from the adrenal medulla by splanchnic nerve stimulation or by the injection of dimethylphenylpiperazinium iodide, nor did they cause antiparasympathetic or parasympathomimetic effects. No action on the central nervous system has been detected. Curare-like neuromuscular block occurred with 10 to 30 times the amount required to block the response to adrenergic nerve stimulation alone and was accompanied by signs of temporary synaptic block in autonomic ganglia. Adrenergic nerve trunks and sensory nerves in the skin were readily blocked for long periods by topical application of bretylium, whereas the phrenic nerve of the rat was not. Bretylium had little effect on gastrointestinal propulsion or on the sensitivity of smooth muscle to acetylcholine, 5-hydroxytryptamine, adrenaline, or noradrenaline, but moderate amounts depressed the peristaltic reflex and the sensitivity of the guinea-pig ileum to histamine. Bretylium caused postural hypotension in the cat in doses which had little effect on the supine blood pressure. Experiments on the nictitating membrane indicated that compensation for the effects of bretylium on low rates of stimulation of postganglionic sympathetic nerves could be attained by a small increase in the rate of stimulation, whereas compensation for its effects on high rates required an increase in the rate of stimulation beyond physiological limits.

Full text

PDF
536

Images in this article

539Fig. 3
on p.539

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAIN W. A., FIELDEN R. In-vitro formation of noradrenaline from dopamine by human tissue. Lancet. 1957 Sep 7;273(6993):472–473. doi: 10.1016/s0140-6736(57)90775-4. [DOI] [PubMed] [Google Scholar]
  2. BROWN G. L., GILLESPIE J. S. The output of sympathetic transmitter from the spleen of the cat. J Physiol. 1957 Aug 29;138(1):81–102. doi: 10.1113/jphysiol.1957.sp005839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. COUPLAND R. E. The effects of insulin, reserpine and choline 2:6-xylylether bromide on the adrenal medulla and on medullary autografts in the rat. J Endocrinol. 1958 Jul;17(2):191–196. doi: 10.1677/joe.0.0170191. [DOI] [PubMed] [Google Scholar]
  4. EDGE N. D., MASON D. F., WYLLIE J. H. Some actions of substituted choline phenyl ethers, particularly of choline 2:6-xylyl ether. Br J Pharmacol Chemother. 1957 Sep;12(3):312–319. doi: 10.1111/j.1476-5381.1957.tb00140.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. EXLEY K. A. The blocking action of choline 2:6-xylyl ether bromide on adrenergic nerves. Br J Pharmacol Chemother. 1957 Sep;12(3):297–305. doi: 10.1111/j.1476-5381.1957.tb00138.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Finkleman B. On the nature of inhibition in the intestine. J Physiol. 1930 Sep 18;70(2):145–157. doi: 10.1113/jphysiol.1930.sp002683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gaddum J. H., Peart W. S., Vogt M. The estimation of adrenaline and allied substances in blood. J Physiol. 1949 Jun 15;108(4):467–481. doi: 10.1113/jphysiol.1949.sp004350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. HEY P., WILLEY G. L. Choline 2 : 6-xylyl ether bromide; an active quaternary local anaesthetic. Br J Pharmacol Chemother. 1954 Dec;9(4):471–475. doi: 10.1111/j.1476-5381.1954.tb00863.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. NASMYTH P. A., ANDREWS W. H. The antagonism of cocaine to the action of choline 2,6-xylyl ether bromide at sympathetic nerve endings. Br J Pharmacol Chemother. 1959 Dec;14:477–483. doi: 10.1111/j.1476-5381.1959.tb00951.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. PATON W. D. M. The paralysis of autonomic ganglia, with special reference to the therapeutic effect of ganglion-blocking drugs. Br Med J. 1951 Apr 14;1(4710):773–778. doi: 10.1136/bmj.1.4710.773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. PERRY W. L. M. Acetylcholine release in the cat's superior cervical ganglion. J Physiol. 1953 Mar;119(4):439–454. doi: 10.1113/jphysiol.1953.sp004858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. STEWART G. A. The actions of digitalis leaf preparations and of cardiac glycosides on the isolated right ventricle of the guinea pig. J Pharm Pharmacol. 1958 Dec;10(12):741–754. doi: 10.1111/j.2042-7158.1958.tb10368.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES